Tuberculosis News and Research

Latest Tuberculosis News and Research

Rutgers researchers to explore ways for tackling emerging fungal infections

In recent years, hospitals nationwide have been reporting an increase in life-threatening illnesses resulting from a deadly fungal infection caused by the yeast Candida auris that can enter the bloodstream. This yeast is difficult to identify and often does not respond to commonly used antifungal drugs, leading to high mortality.

23 Oct 2017

Scientists develop novel antimicrobials to tackle multidrug-resistant bacteria

Scientists at the University of Surrey in collaboration with research partners at the University of Sheffield and University of Würzburg, Germany, have developed novel antimicrobials, which could be used to treat infections, caused by multidrug-resistant bacteria.

23 Oct 2017

New model predicts how E. coli bacteria respond to temperature changes, genetic mutations

Researchers at the University of California San Diego have developed a genome-scale model that can accurately predict how E. coli bacteria respond to temperature changes and genetic mutations.

13 Oct 2017

NTNU researchers reveal how HCV converts innocent cells into virus factories

The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus "factories" that quickly go into mass production.

13 Oct 2017

Academy of Medical Sciences announces new UK-India scheme to address challenge of AMR

The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).

12 Oct 2017

TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs

TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.

11 Oct 2017

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.

10 Oct 2017

NIH awards $2.3 million grant to Umass Amherst microbiologist for TB research

The National Institutes of Health announced today that microbiologist Sloan Siegrist at the University of Massachusetts Amherst has received a five-year, $2.3 million National Institutes of Health New Innovator Award, which supports "unusually innovative research from early career investigators," to study the bacterium that causes tuberculosis (TB).

5 Oct 2017

Study finds no association between BCG vaccine and childhood asthma

Childhood asthma is a serious public health challenge in Québec and throughout the world. Although the immune mechanisms implicated in the development of childhood asthma are not fully understood, some studies seem to suggest that the BCG vaccine, used in tuberculosis prevention, may have a protective effect on childhood asthma.

3 Oct 2017

WHO report shows serious lack of new antibiotics to combat drug-resistant infections

A report, Antibacterial agents in clinical development - an analysis of the antibacterial clinical development pipeline, including tuberculosis, launched today by WHO shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.

20 Sep 2017

New antibiotic development slowing - warns World Health Organization

According to a new report from the World Health Organization (WHO) released yesterday, antibiotics development at present is not at par with the rising antimicrobial resistance worldwide and soon the demand may outgrow the supply. The WHO warns that this could mean that pathogens causing these infections could mean a great threat for humans in the coming years.

19 Sep 2017

'Pocket' project develops new low-cost test for accurate TB detection

Tuberculosis (TB) is a major global health issue. According to the World Health Organisation (WHO), every year there are worldwide 8.8 million new active TB cases and nearly 2 million TB deaths - 5000 every day - mostly in the poorest communities of the developing world.

19 Sep 2017

Global Burden of Disease study reveals latest findings on state of world’s health

Today, the Global Burden of Disease study publishes its latest global estimates for the state of the world’s health in The Lancet. The GBD is the only annual, comprehensive, peer-reviewed assessment of global trends in health, providing global and national estimates on more than 330 diseases, causes of death, and injuries in 195 countries and territories worldwide.

18 Sep 2017

Scientists make significant discovery in efforts to develop vaccine against global pathogens

Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

15 Sep 2017

Review assesses safety, effectiveness of corticosteroids for treating TB pericarditis

Researchers from South Africa and Canada have carried out a Cochrane review update to assess the safety and effectiveness of corticosteroids for treating tuberculous pericarditis.

14 Sep 2017

Hurricane redux: A doctor tending to Texans taps lessons learned from Katrina

As Dr. Ruth Berggren digests the calamity affecting her new home state of Texas, she admits to some PTSD.

6 Sep 2017

BCG vaccine protects against infection in adulthood when most transmission occurs, study shows

Previously thought to be effective for 10-15 years, a new case-control study found that if given in early teenage years (12-13), the Bacillus Calmette-Guérin (BCG) vaccine protected over 50% of UK children against TB for at least 20 years, then waned.

1 Sep 2017

Protein distribution channel may be new target for combating pathogenic bacterium

A bacterium that attacks people suffering from chronic lung disease and compromised immune systems could be halted by disrupting the distribution channels the organism uses to access the nutrient-rich cytoplasm of its host cell.

31 Aug 2017

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

26 Aug 2017

ESCMID conference brings together renowned experts to address most pressing questions on vaccines

Registration is open for the 4th ESCMID Conference on Vaccines. New and old diseases in children and adults: unmet needs in Dubrovnik, Croatia, Friday 8 September to Sunday 10 September 2017. Registration for bona fide journalists is free.

26 Aug 2017

Tuberculosis News and Research

Latest Tuberculosis News and Research

Rutgers researchers to explore ways for tackling emerging fungal infections

Scientists develop novel antimicrobials to tackle multidrug-resistant bacteria

New model predicts how E. coli bacteria respond to temperature changes, genetic mutations

NTNU researchers reveal how HCV converts innocent cells into virus factories

Academy of Medical Sciences announces new UK-India scheme to address challenge of AMR

TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

NIH awards $2.3 million grant to Umass Amherst microbiologist for TB research

Study finds no association between BCG vaccine and childhood asthma

WHO report shows serious lack of new antibiotics to combat drug-resistant infections

New antibiotic development slowing - warns World Health Organization

'Pocket' project develops new low-cost test for accurate TB detection

Global Burden of Disease study reveals latest findings on state of world’s health

Scientists make significant discovery in efforts to develop vaccine against global pathogens

Review assesses safety, effectiveness of corticosteroids for treating TB pericarditis

Hurricane redux: A doctor tending to Texans taps lessons learned from Katrina

BCG vaccine protects against infection in adulthood when most transmission occurs, study shows

Protein distribution channel may be new target for combating pathogenic bacterium

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

ESCMID conference brings together renowned experts to address most pressing questions on vaccines

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in